Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PDL BIOPHARMA INC Financial Overview

  • Income Statement: PDLI
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 294.27 M 258.92 M 35.34 M 12.01%
    Gross Profit 271.78 M 194.43 M 77.34 M 28.46%
    Net Income Before Extra Items/Preferred Div 68.39 M -21.06 M 89.45 M 130.80%
    Operating Income 242.93 M -1.62 M 244.54 M 100.67%
    View Full Report

  • Cash Flow: PDLI
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -878.54 M 22.00 M -900.54 M 102.50%
    Net Cash Flow - Investing -587.02 M -72.66 M -514.36 M 87.62%
    Net Cash Flow/Operating Activities 80.15 M 66.97 M 13.18 M 16.44%
    View Full Report

  • Balance Sheet: PDLI

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 187.23 M 1.15 B -966.64 M -516.29%
    Total Liabilities 539.80 M 646.26 M -106.46 M -19.72%
    Shareholders Equity -352.57 M 507.61 M -860.18 M 243.97%
    View Full Report

  • Key Ratios / Statistics: PDLI

    • Valuation

      Price/Earnings (TTM) 15.07
      Price/Sales (TTM) 3.53
      Price/Book (MRQ) -3.07
      Price/Cash Flow (TTM) 7.78

    • Profitability

      Gross Margin 92.36
      Operating Margin 82.55
      Profit Margin 23.24

    • Dividends

      Dividend Paid (TTM) 1.00
      Payout Ratio % (TTM) 86.21

    • Financial Strength

      Quick Ratio (MRQ) 5.11
      Current Ratio (MRQ) 3.07
      Long Term Debt-to-Equity (MRQ) -144.96

    • Management Effectiveness

      Return on Equity (TTM) 18.34
      Return on Assets (TTM) 42.86
      Return on Investments (TTM) 13.04
    View All Key Ratios